Group 6 Copy 274
0
    Please wait...

    About This Project

    The treatments available for glioblastoma multiform (GBM) patients provide a minimal survival benefit, and novel methodologies to detect and treat GBM are needed. This project focuses on a gene product called noncoding RNA, a molecule that regulates the expression of tumor-causing genes at the RNA level. The Institute identified novel RNA transcripts detectable in human cancer. We will determine the consequences when cells lose these transcripts and will develop noncoding RNA biomarkers for GBM.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

    I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

    CRISPR Capsules: Packaging Cas9 with bacterial outer membrane vesicles

    NU iGEM is creating a delivery system for an innovative antibiotic method centered around CRISPR, a powerful...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Backer Badge Funded